Analyst firms · Leerink Partners · ITOS
Leerink Partners ITOS price target and rating history
iTeos Therapeutics Inc. (ITOS) · Health Care
Leerink Partners rates iTeos Therapeutics Inc. (ITOS) Market Perform with a $9 price target, as of its latest action on May 14, 2025. It has published 3 rating actions on ITOS since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Market Perform
- Price target
- $9
- Median target, all firms
- Too few
- Actions on ITOS
- 3
Leerink Partners price target on ITOS
Every Leerink Partners rating on ITOS
- May 14, 2025
- Nov 12, 2021
- Aug 13, 2021
Questions about Leerink Partners and ITOS
- What is Leerink Partners's price target for ITOS?
- Leerink Partners's latest stated price target for iTeos Therapeutics Inc. (ITOS) is $9, from its action on May 14, 2025.
- What is Leerink Partners's rating on ITOS?
- Leerink Partners rates ITOS Market Perform, a neutral rating, as of May 14, 2025.
- When did Leerink Partners last change its view on ITOS?
- On May 14, 2025, Leerink Partners downgrades to Market Perform from Outperform, price target $9.
All Leerink Partners ratingsITOS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.